TAK-831-1001

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAK-831-1001, covering 2018-02-06 to 2018-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants [Phase 1]